Search research articles
Contact Us
Filters
Showing results (81-90 of 343) with videos related to
Page
of 35
Sort By:
Molecular Cancer Research : MCR
|
November 5, 2014
The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer
Leo Y Luo, Eejung Kim, Hiu Wing Cheung, et al.
Investigational New Drugs
|
August 15, 2018
Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxel in patients with previously untreated metastatic pancreatic ductal adenocarcinoma
Kimmie Ng, Andrew Hendifar, Alexander Starodub, et al.
Cell
|
June 2, 2007
The tumor suppressor PP2A Abeta regulates the RalA GTPase
Anna A Sablina, Wen Chen, Jason D Arroyo, et al.
Plos One
|
September 21, 2011
High throughput interrogation of somatic mutations in high grade serous cancer of the ovary
Ursula A Matulonis, Michelle Hirsch, Emanuele Palescandolo, et al.
Nature
|
January 28, 2025
Author Correction: An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA
Yoshiko Maida, Mami Yasukawa, Miho Furuuchi, et al.
Nature
|
August 25, 2009
An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA
Yoshiko Maida, Mami Yasukawa, Miho Furuuchi, et al.
Cold Spring Harbor Symposia on Quantitative Biology
|
November 6, 2016
Functional Genomic Characterization of Cancer Genomes
Thomas P Howard, Francisca Vazquez, Aviad Tsherniak, et al.
Cancer Research
|
October 7, 2004
Signaling and transcriptional changes critical for transformation of human cells by simian virus 40 small tumor antigen or protein phosphatase 2A B56gamma knockdown
Carlos S Moreno, Sumathi Ramachandran, Danita G Ashby, et al.
Genome Biology
|
December 21, 2021
Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects
Joshua M Dempster, Isabella Boyle, Francisca Vazquez, et al.
Molecular and Cellular Biology
|
January 15, 2014
Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation
Boris G Wilson, Katherine C Helming, Xiaofeng Wang, et al.
Page
of 35
Search research articles
Search
Showing results (81-90 of 343) with videos related to
Sort By:
Page
of 35
Molecular Cancer Research : MCR
|
November 5, 2014
The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer
Leo Y Luo, Eejung Kim, Hiu Wing Cheung, et al.
Investigational New Drugs
|
August 15, 2018
Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxel in patients with previously untreated metastatic pancreatic ductal adenocarcinoma
Kimmie Ng, Andrew Hendifar, Alexander Starodub, et al.
Cell
|
June 2, 2007
The tumor suppressor PP2A Abeta regulates the RalA GTPase
Anna A Sablina, Wen Chen, Jason D Arroyo, et al.
Plos One
|
September 21, 2011
High throughput interrogation of somatic mutations in high grade serous cancer of the ovary
Ursula A Matulonis, Michelle Hirsch, Emanuele Palescandolo, et al.
Nature
|
January 28, 2025
Author Correction: An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA
Yoshiko Maida, Mami Yasukawa, Miho Furuuchi, et al.
Nature
|
August 25, 2009
An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA
Yoshiko Maida, Mami Yasukawa, Miho Furuuchi, et al.
Cold Spring Harbor Symposia on Quantitative Biology
|
November 6, 2016
Functional Genomic Characterization of Cancer Genomes
Thomas P Howard, Francisca Vazquez, Aviad Tsherniak, et al.
Cancer Research
|
October 7, 2004
Signaling and transcriptional changes critical for transformation of human cells by simian virus 40 small tumor antigen or protein phosphatase 2A B56gamma knockdown
Carlos S Moreno, Sumathi Ramachandran, Danita G Ashby, et al.
Genome Biology
|
December 21, 2021
Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects
Joshua M Dempster, Isabella Boyle, Francisca Vazquez, et al.
Molecular and Cellular Biology
|
January 15, 2014
Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation
Boris G Wilson, Katherine C Helming, Xiaofeng Wang, et al.
Page
of 35